On the whole, there is no benefit to adding docetaxel at the end of radiation and then continuing with long-term ADT in high risk men. One trial (GETUG-12) found a benefit to chemo PRE-treatment.
Another randomized clinical trial sho... - Prostate Cancer N...
Another randomized clinical trial shows no benefit to adding docetaxel to radiation + ADT in high risk patients
Written by
Tall_Allen
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Adding ADT to external beam radiation only benefits unfavorable risk patients
intermediate risk\\" patients are sometimes overtreated by doctors who give them adjuvant ADT. This...
Optimal duration of adjuvant ADT depends on the type of radiation used for high-risk patients
severe late-term urinary side effects (among 19% in the ASCENDE-RT trial), while the late-term...
Whole-pelvic radiation therapy for high-risk patients
If you have high-risk PCa, you probably should have whole pelvic radiation:...
Short-term vs Long-Term ADT for High Risk Men
to predict which high-risk men do or don't benefit from short-term ADT vs long-term ADT. Their...
No difference in SBRT vs conventionally fractionated radiation for intermediate risk patients
eferred-treatment-for.html
For low-risk patients and even some favorable intermediate-risk patients
Early side effects of docetaxel
Are there benefits of ADT Beyond 18 months?
